Phacilitate Leaders World

Avoid Tripping at the Last Mile [webinar]

Avoid Tripping at the Last Mile [webinar]

Your therapy is cryopreserved and ready to change a patient's life. Is the cryogenic ecosystem in place to ensure you do not trip at the last mile?

Modern medicine is evolving to support the advent of cellular-based therapies and treatments. These therapies provide new promise and opportunity to so many patients. However, cellular-based therapies have specific handling requirements related to temperature.

In this case, shelf-life is only preserved when the temperature can be maintained below the glass transition of water (Tg). Any increase in temperature can result in unintended damage to cellular products. Whether you are handling vitrified eggs and embryos, or you are handling a blockbuster in CAR-T, your cryogenic eco-system needs to be rock solid. 

Join this webinar to gain perspective from two global leaders with decades of experience in handling inventories of high value, cryopreserved cellular products. 

Sign up for this webinar

WEBINAR: Avoid Tripping at the Last Mile

 

Details

Date: October 25th 2018

Time: 4pm BST | 11am EST | 8am PST

 

Moderator:

David Lewandowski, Global Product Marketing Manager, Brooks Life Science Systems

Speakers:

Kaj Rydman, Vice President, Reproductive Operations, California Cryobank Life Sciences

Albert Ribickas, BMT/QC Laboratories Manager, Cell Therapies Facility, Moffitt Cancer Center

Sign up

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK